Neuropace Stock Price History
NPCE Stock | USD 13.52 0.25 1.82% |
If you're considering investing in Neuropace Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neuropace stands at 13.52, as last reported on the 25th of February, with the highest price reaching 14.16 and the lowest price hitting 13.46 during the day. Neuropace appears to be somewhat reliable, given 3 months investment horizon. Neuropace has Sharpe Ratio of 0.15, which conveys that the firm had a 0.15 % return per unit of risk over the last 3 months. By analyzing Neuropace's technical indicators, you can evaluate if the expected return of 0.55% is justified by implied risk. Please exercise Neuropace's Mean Deviation of 3.1, risk adjusted performance of 0.1396, and Downside Deviation of 3.34 to check out if our risk estimates are consistent with your expectations.
The current year's Total Stockholder Equity is expected to grow to about 24.9 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 27 M. . At present, Neuropace's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.24, whereas Price To Operating Cash Flows Ratio is forecasted to decline to (12.78). Neuropace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Neuropace |
Sharpe Ratio = 0.1475
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | NPCE | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.73 actual daily | 33 67% of assets are more volatile |
Expected Return
0.55 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Neuropace is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuropace by adding it to a well-diversified portfolio.
Price Book 43.8176 | Enterprise Value Ebitda (16.94) | Price Sales 5.6259 | Shares Float 18.5 M | Wall Street Target Price 17.5714 |
Neuropace Stock Price History Chart
There are several ways to analyze Neuropace Stock price data. The simplest method is using a basic Neuropace candlestick price chart, which shows Neuropace price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 24, 2025 | 14.69 |
Lowest Price | November 26, 2024 | 10.2 |
Neuropace February 25, 2025 Stock Price Synopsis
Various analyses of Neuropace's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neuropace Stock. It can be used to describe the percentage change in the price of Neuropace from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neuropace Stock.Neuropace Price Rate Of Daily Change | 0.98 | |
Neuropace Price Action Indicator | (0.42) | |
Neuropace Price Daily Balance Of Power | (0.36) |
Neuropace February 25, 2025 Stock Price Analysis
Neuropace Stock Price History Data
The price series of Neuropace for the period between Wed, Nov 27, 2024 and Tue, Feb 25, 2025 has a statistical range of 5.74 with a coefficient of variation of 12.54. The daily prices for the period are spread out with arithmetic mean of 11.95. The median price for the last 90 days is 11.91.Open | High | Low | Close | Volume | ||
02/25/2025 | 13.79 | 14.16 | 13.46 | 13.52 | ||
02/24/2025 | 13.79 | 14.16 | 13.46 | 13.52 | 221,410 | |
02/21/2025 | 14.20 | 14.21 | 13.25 | 13.77 | 532,543 | |
02/20/2025 | 13.44 | 14.39 | 13.06 | 14.23 | 455,934 | |
02/19/2025 | 13.25 | 13.74 | 12.90 | 13.45 | 321,309 | |
02/18/2025 | 13.11 | 13.47 | 12.36 | 13.44 | 254,117 | |
02/14/2025 | 10.31 | 13.65 | 10.30 | 12.31 | 1,959,813 | |
02/13/2025 | 12.20 | 12.20 | 11.62 | 12.09 | 103,743 | |
02/12/2025 | 12.08 | 12.58 | 11.68 | 12.09 | 77,451 | |
02/11/2025 | 12.35 | 12.65 | 12.05 | 12.30 | 89,892 | |
02/10/2025 | 12.82 | 12.84 | 12.02 | 12.52 | 152,182 | |
02/07/2025 | 13.53 | 13.68 | 12.50 | 13.12 | 133,793 | |
02/06/2025 | 14.36 | 14.40 | 13.53 | 13.66 | 366,673 | |
02/05/2025 | 13.91 | 14.40 | 13.72 | 14.29 | 114,376 | |
02/04/2025 | 13.52 | 14.01 | 13.27 | 13.90 | 157,940 | |
02/03/2025 | 13.64 | 14.00 | 13.21 | 13.61 | 154,505 | |
01/31/2025 | 14.14 | 14.27 | 13.50 | 13.76 | 163,085 | |
01/30/2025 | 14.99 | 15.04 | 13.55 | 14.19 | 462,937 | |
01/29/2025 | 14.42 | 15.00 | 14.15 | 14.69 | 319,875 | |
01/28/2025 | 14.18 | 14.95 | 13.77 | 14.13 | 99,683 | |
01/27/2025 | 14.42 | 15.02 | 13.90 | 14.24 | 222,929 | |
01/24/2025 | 14.02 | 15.11 | 13.69 | 14.69 | 153,619 | |
01/23/2025 | 14.01 | 14.19 | 13.14 | 14.02 | 186,311 | |
01/22/2025 | 14.00 | 14.41 | 13.33 | 14.04 | 359,080 | |
01/21/2025 | 13.77 | 13.77 | 12.25 | 13.06 | 258,490 | |
01/17/2025 | 12.03 | 12.09 | 11.75 | 11.97 | 83,546 | |
01/16/2025 | 12.05 | 12.22 | 11.37 | 11.91 | 110,352 | |
01/15/2025 | 12.26 | 12.41 | 11.75 | 12.00 | 101,494 | |
01/14/2025 | 12.32 | 12.65 | 11.75 | 11.84 | 79,587 | |
01/13/2025 | 12.00 | 12.60 | 11.85 | 12.11 | 167,093 | |
01/10/2025 | 13.65 | 13.65 | 11.18 | 11.94 | 284,614 | |
01/08/2025 | 12.41 | 12.50 | 11.75 | 12.01 | 69,884 | |
01/07/2025 | 11.95 | 12.49 | 11.41 | 12.42 | 61,151 | |
01/06/2025 | 11.65 | 12.53 | 11.52 | 11.93 | 92,595 | |
01/03/2025 | 11.57 | 12.46 | 11.27 | 11.57 | 41,880 | |
01/02/2025 | 11.36 | 11.66 | 11.12 | 11.58 | 37,134 | |
12/31/2024 | 11.02 | 11.45 | 10.43 | 11.19 | 58,497 | |
12/30/2024 | 10.65 | 11.07 | 10.44 | 10.87 | 45,067 | |
12/27/2024 | 11.23 | 11.62 | 10.36 | 10.67 | 48,541 | |
12/26/2024 | 11.06 | 11.39 | 10.95 | 11.35 | 56,613 | |
12/24/2024 | 11.35 | 11.44 | 11.10 | 11.14 | 26,277 | |
12/23/2024 | 11.47 | 11.90 | 11.08 | 11.44 | 44,113 | |
12/20/2024 | 11.00 | 11.59 | 10.76 | 11.53 | 188,294 | |
12/19/2024 | 11.01 | 11.66 | 10.76 | 11.14 | 55,500 | |
12/18/2024 | 11.69 | 12.23 | 9.92 | 10.64 | 86,205 | |
12/17/2024 | 11.59 | 12.41 | 11.30 | 11.52 | 103,674 | |
12/16/2024 | 10.98 | 11.66 | 10.54 | 11.47 | 79,703 | |
12/13/2024 | 10.98 | 11.09 | 10.00 | 11.03 | 56,346 | |
12/12/2024 | 10.95 | 11.21 | 10.35 | 10.91 | 79,093 | |
12/11/2024 | 11.56 | 12.00 | 10.90 | 11.08 | 86,963 | |
12/10/2024 | 10.71 | 11.68 | 10.47 | 11.51 | 76,874 | |
12/09/2024 | 11.29 | 11.45 | 10.94 | 10.95 | 32,000 | |
12/06/2024 | 11.46 | 11.55 | 11.20 | 11.28 | 45,107 | |
12/05/2024 | 11.09 | 11.83 | 10.89 | 11.28 | 64,882 | |
12/04/2024 | 11.89 | 11.89 | 10.70 | 11.19 | 94,129 | |
12/03/2024 | 11.25 | 12.43 | 11.09 | 11.93 | 77,665 | |
12/02/2024 | 10.87 | 11.73 | 10.61 | 11.29 | 70,843 | |
11/29/2024 | 10.43 | 10.72 | 10.42 | 10.60 | 21,029 | |
11/27/2024 | 10.20 | 10.46 | 9.79 | 10.25 | 61,622 | |
11/26/2024 | 10.67 | 10.67 | 10.10 | 10.20 | 62,803 | |
11/25/2024 | 9.40 | 10.77 | 9.40 | 10.66 | 169,951 |
About Neuropace Stock history
Neuropace investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuropace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuropace will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuropace stock prices may prove useful in developing a viable investing in Neuropace
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 29.7 M | 27 M | |
Net Loss | -42.4 M | -44.5 M |
Neuropace Quarterly Net Working Capital |
|
Neuropace Stock Technical Analysis
Neuropace technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
All Next | Launch Module |
Neuropace Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neuropace's price direction in advance. Along with the technical and fundamental analysis of Neuropace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuropace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1396 | |||
Jensen Alpha | 0.6853 | |||
Total Risk Alpha | 0.659 | |||
Sortino Ratio | 0.2036 | |||
Treynor Ratio | (20.39) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |